Feds add a new tool to fight fraud at drug firms

Share this article:
Feds add a new tool to fight fraud at drug firms
Feds add a new tool to fight fraud at drug firms

Used for the first time in the recent $3 billion healthcare fraud settlement with Glaxo­SmithKline (GSK), a new enforcement tool has joined the federal government's list of options to rein in improper medical product promotion. The Executive Financial Recoupment Program was added to the 122-page corporate integrity agreement GSK signed with the Department of Justice in June.

The agreement says this “puts at risk of forfeiture and recoupment an amount equivalent to up to three years of annual performance pay (i.e., annual bonus, plus long term incentives) for an executive who is discovered to have been involved in any significant misconduct.

So far, the government has not commented on why it added a recoupment program into the GSK agreement, or if it plans to expand its use of this tool.

“However, past practice has been that new [corporate integrity agreement] provisions become the norm,” the analysis notes. “Therefore, healthcare companies under government investigation should anticipate having to deal with these recoupment issues in the future.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric